Clifford Selsky serves as Executive at Immune Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Clifford Selsky has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 27, 2021 involved receiving (via award) 101,579 shares valued at $0.
Clifford Selsky currently holds 101,579 shares of Immune Therapeutics, Inc. (IMUN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Clifford Selsky has been a net neutral trader of IMUN stock. They have purchased $0 and sold $0 worth of shares.
Clifford Selsky's most recent insider trade was on Jul 27, 2021, when they sold 101,579 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |